TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2008

Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.

Olwen M Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.